Literature DB >> 5910108

Late results of treatment of chronic drug-resistant pulmonary tuberculosis.

A R Somner, A A Brace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5910108      PMCID： PMC1844514          DOI： 10.1136/bmj.1.5490.775

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.

Authors:  M ZIERSKI
Journal:  Tubercle       Date:  1964-06

2.  CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.

Authors:  E JANCIK; M ZELENKA; J TOUSEK; M MAKOVA
Journal:  Tubercle       Date:  1963-12

3.  Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis.

Authors:  A R SOMNER; A A BRACE
Journal:  Tubercle       Date:  1962-12
  3 in total
  6 in total

Review 1.  Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors:  Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

Review 2.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

3.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

4.  [Contribution to the problem of resistance stability of the so-called polyresistant mycobacteria from patients with widespread chronic pulmonary tuberculosis].

Authors:  J Tousek; L Trnka; A Havel
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1968

5.  Drug-resistant tuberculosis in Waltham forest, 1953-68. A clinical and epidemiological study.

Authors:  R S Francis
Journal:  Thorax       Date:  1971-07       Impact factor: 9.139

6.  Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.

Authors:  Kwok-Chiu Chang; Chi-Chiu Leung; Wing-Wai Yew; Eric Chung-Ching Leung; Wai-Man Leung; Cheuk-Ming Tam; Ying Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.